281 related articles for article (PubMed ID: 1539301)
21. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
Arrieta J; Rodríguez-Carmona A; Remón C; Pérez-Fontán M; Ortega F; Sánchez Tomero JA; Selgas R
Nefrologia; 2011; 31(5):505-13. PubMed ID: 21959716
[No Abstract] [Full Text] [Related]
22. [Regular dialysis and kidney transplantation as complementary methods of treatment--medical and economic aspects].
Zec J; Orlić P; Vujaklija-Stipanović K; Razmilić D; Valencić M; Cohar F; Grzetić M; Matić-Glazar D
Lijec Vjesn; 1987; 109(11-12):458-60. PubMed ID: 3320650
[No Abstract] [Full Text] [Related]
23. [Kidney transplantation, a viable alternative for end-stage kidney failure].
Cuero CJ
Rev Med Panama; 1997; 22(2):35-8. PubMed ID: 10997186
[TBL] [Abstract][Full Text] [Related]
24. Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
[TBL] [Abstract][Full Text] [Related]
25. [Self dialysis: a new method of treatment for end-stage renal disease].
Fournier G; Gaillard JL; Matha N; Man NK
Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
[TBL] [Abstract][Full Text] [Related]
26. A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies.
Lee CP; Chertow GM; Zenios SA
Med Decis Making; 2006; 26(5):535-49. PubMed ID: 16997929
[TBL] [Abstract][Full Text] [Related]
27. [Sociological diagnosis in the selection of rehabilitation methods for the uremic patient].
Urdaneta Carruyo ER; Otañez Pineda E; Gordillo-Paniagua G
Bol Med Hosp Infant Mex; 1981; 38(5):777-86. PubMed ID: 7034743
[No Abstract] [Full Text] [Related]
28. Using the pharmacoepidemiology approach to evaluate the first-year posttransplantation ambulatory health care cost from the Longitudinal Health Insurance Database (2001 to 2006) in Taiwan.
Lee EK; Cham TM; Tseng PL
Transplant Proc; 2010 Apr; 42(3):957-60. PubMed ID: 20430215
[TBL] [Abstract][Full Text] [Related]
29. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
[No Abstract] [Full Text] [Related]
31. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.
Lamas Barreiro JM; Alonso Suárez M; Saavedra Alonso JA; Gándara Martínez A
Nefrologia; 2011; 31(6):656-63. PubMed ID: 22130280
[TBL] [Abstract][Full Text] [Related]
32. [Comparative aspects of the cost/benefits ratio in dialysis-transplant].
Guzzanti E; Picca S
Minerva Chir; 1989 Feb; 44(4):793-800. PubMed ID: 2497406
[No Abstract] [Full Text] [Related]
33. Cost-effectiveness studies of renal transplantation.
Karlberg I; Nyberg G
Int J Technol Assess Health Care; 1995; 11(3):611-22. PubMed ID: 7591556
[TBL] [Abstract][Full Text] [Related]
34. Myths and facts in end-stage renal disease treatment.
Potter DJ
Ariz Med; 1984 Feb; 41(2):107-8. PubMed ID: 6367713
[No Abstract] [Full Text] [Related]
35. Preventable kidney failure: the cost of diabetes neglect?
Endre ZH; Beaven D; Buttimore A
N Z Med J; 2006 Dec; 119(1246):U2338. PubMed ID: 17151712
[TBL] [Abstract][Full Text] [Related]
36. Is living kidney donation the answer to the economic problem of end-stage renal disease?
Klarenbach S; Barnieh L; Gill J
Semin Nephrol; 2009 Sep; 29(5):533-8. PubMed ID: 19751899
[TBL] [Abstract][Full Text] [Related]
37. High-efficiency kidney transplantation: concept, technique, results, and cost analysis.
Lopez-Neblina F; Alvarez JH; Finkelstein LI
Transplant Proc; 2000 Feb; 32(1):141-2. PubMed ID: 10700999
[No Abstract] [Full Text] [Related]
38. Transplantation and the end-stage renal disease program.
Heitman J
Pharos Alpha Omega Alpha Honor Med Soc; 1993; 56(1):2-8. PubMed ID: 8434036
[No Abstract] [Full Text] [Related]
39. [Costs of care in uremia. How much does kidney transplantation cost?].
Jakobsen A; Albrechtsen D; Sødal G; Flatmark A; Fauchald P; Vartdal F
Tidsskr Nor Laegeforen; 1990 Jan; 110(3):338-41. PubMed ID: 2309175
[TBL] [Abstract][Full Text] [Related]
40. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
Manns B; Meltzer D; Taub K; Donaldson C
Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
